Economic evaluation of a randomized controlled trial comparing mifepristone and misoprostol with misoprostol alone in the treatment of early pregnancy loss.
Publication year
2022Source
PLoS One, 17, 2, (2022), article e0262894ISSN
Publication type
Article / Letter to editor

Display more detailsDisplay less details
Organization
Gynaecology
Radboudumc Extern
Health Evidence
IQ Healthcare
Cardiology
Journal title
PLoS One
Volume
vol. 17
Issue
iss. 2
Subject
Radboudumc 10: Reconstructive and regenerative medicine RIMLS: Radboud Institute for Molecular Life Sciences; Radboudumc 17: Women's cancers RIHS: Radboud Institute for Health Sciences; Radboudumc 18: Healthcare improvement science RIHS: Radboud Institute for Health SciencesThis item appears in the following Collection(s)
- Academic publications [234108]
- Electronic publications [116863]
- Faculty of Medical Sciences [89175]
- Open Access publications [83955]
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.